The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1248 Weight Loss articles
Many people turn to GLP-1 drugs like Ozempic for weight loss, but cost can be a barrier. Affordable alternatives like berberine offer hope, yet experts caution against unrealistic hype. This article examines its benefits, side effects, and potential as a weight loss aid.
As new health goals emerge in January, weight loss medications like Mounjaro gain popularity, but an NHS notice warns about potential interactions with birth control and hormone therapy. Estimates indicate hundreds of thousands are using these drugs privately, with guidelines stressing extra precautions for absorption issues.
A recent study reveals that GLP-1 medications can significantly decrease severe asthma episodes among adolescents who are overweight or obese. Researchers found a notable reduction in emergency room visits and steroid use. Experts suggest these drugs offer dual benefits for weight control and asthma management.
Singer Jelly Roll achieved remarkable weight loss without relying on medications, choosing instead to address his eating habits as an addiction. He explains the surprising factors behind his decision and the profound impacts on his life. This natural path has revitalized his health and relationships.
GLP-1 injectable treatments have surged in popularity in India, prompting medical professionals to emphasize comprehensive diagnostic evaluations before initiating therapy. Key assessments cover metabolic health, organ function, and specific risks to guarantee patient safety. This approach underscores the importance of medical oversight for these potent medications.
In Ohio, Representative Josh Williams is sponsoring House Bill 388 to reimburse state workers for GLP-1 medications purchased directly from manufacturers, bypassing high pharmacy costs. This initiative follows the state's decision to drop coverage in early 2025 due to expenses, with the bill proposing a more affordable reimbursement model. Williams emphasizes that this approach could slash costs while providing stable access to essential health treatments.
Demi Lovato ushered in the new year by showcasing her 22kg weight loss through bikini photos on Instagram. Admirers complimented her physique, and she recounted a significant 2025 involving her wedding and latest album release. During a chat, she detailed her drug-free routine and plans for an energetic tour.
Pharmaceutical giants like Novo Nordisk and Eli Lilly are transforming GLP-1 drugs into everyday consumer products, introducing oral versions and emphasizing cash-pay models. This shift, driven by telehealth and apps, aims to make weight loss as accessible as online shopping, while experts raise concerns about medical oversight.
The United States Food and Drug Administration has greenlit the initial tablet form of a GLP-1 drug designed for shedding pounds, which might considerably broaden availability of obesity therapies. Produced by the Danish firm Novo Nordisk, this daily Wegovy pill is set to debut in early January, with clinical trial participants averaging a 16.6% drop in body weight.
